VitaFlowTM II Transcatheter Aortic Valve System Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 178 participants.
Also called NCT03575039
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 178 participants
- Registry
-
NCT03575039
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT03575039. Allocation not applicable; no masking; primary purpose treatment. Start 2018-08 (anticipated); primary completion 2020-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- VitaFlowTM II Transcatheter Aortic Valve System Study
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- VitaFlow II Transcatheter Aortic Valve System
- Lead sponsor
- Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Record details
- Record id
cardio:ct-nct03575039- Content hash
bbe0b61f8744d3235d67b03c27a6a2a7ef9fc128845e2d9d137ad8e93fa2098d